AEON Biopharma, Inc. announced the approval of a 1-for-72 reverse stock split by its Board of Directors to comply with NYSE American listing requirements. This split will take effect on February 26, ...
The Nasdaq-100 has been in sell-off mode since mid-February, but it officially entered correction territory this month when the losses exceeded 10% from the index's record high. However, history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results